Systemic Treatment for Brain Metastases in NSCLC: A New Chapter

被引：0
|
作者：
Acker, Fabian [1 ]
Althoff, Friederike C. [1 ]
Sebastian, Martin [1 ,2 ,3 ,4 ,5 ]
机构：
[1] Univ Hosp Frankfurt, Dept Med 2, Hematol Oncol, Frankfurt, Germany
[2] German Canc Consortium DKTK, Partner Site Frankfurt Mainz, Mainz, Germany
[3] German Canc Res Ctr, Heidelberg, Germany
[4] Goethe Univ Frankfurt, Frankfurt Canc Inst, Frankfurt, Germany
[5] Univ Hosp Frankfurt, Dept Med 2, Theodor Stern Kai 7, D-60590 Frankfurt, Germany
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 06期
关键词：
NIVOLUMAB PLUS IPILIMUMAB; CELL LUNG-CANCER; PLATINUM-BASED CHEMOTHERAPY; PHASE-III TRIAL; POOLED ANALYSIS; 5-YEAR UPDATE; OPEN-LABEL; FOLLOW-UP; PEMBROLIZUMAB; OUTCOMES;
D O I：
10.1016/j.jtho.2023.03.004
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：678 / 681
页数：4
相关论文
共 50 条
  • [41] BRAIN METASTASES FROM NSCLC: A MONOCENTRIC EXPERIENCE
    Benbrahim, Zineb
    Amaadour, Lamiae
    Boudehna, Lamiae
    Arifi, Samia
    Mellas, Nawfel
    ANNALS OF ONCOLOGY, 2014, 25
  • [42] Impact of systemic treatment on survival after whole brain radiotherapy in patients with brain metastases
    Nieder, Carsten
    Marienhagen, Kirsten
    Dalhaug, Astrid
    Aandahl, Gro
    Haukland, Ellinor
    Pawinski, Adam
    MEDICAL ONCOLOGY, 2014, 31 (04)
  • [43] Impact of systemic treatment on survival after whole brain radiotherapy in patients with brain metastases
    Carsten Nieder
    Kirsten Marienhagen
    Astrid Dalhaug
    Gro Aandahl
    Ellinor Haukland
    Adam Pawinski
    Medical Oncology, 2014, 31
  • [44] Treatment and prevention of CNS metastases in NSCLC
    Gore, Elizabeth M.
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S205 - S207
  • [45] Brain Metastases Secondary to NSCLC: Does the Number of Brain Tumors Treated Matter in the Management of Brain Metastases?
    Amendola, Beatriz
    Wolf, Aizik L.
    Coy, Sammie R.
    Amendola, Marco
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2010, 33 (02): : 198 - 199
  • [46] Profiling and treatment patterns in NSCLC patients with CNS (brain) metastases in Europe and Asia.
    Mari, Ettore
    Mpima, Sheila
    Guglielmetti, Filippo
    Manuguid, Fil S.
    Enschede, Sari Heitner
    Nasuti, Paola
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [47] Multidisciplinary expert opinion on the treatment consensus for patients with EGFR mutated NSCLC with brain metastases
    Ponce, Santiago
    Bruna, Jordi
    Juan, Oscar
    Lopez, Rafael
    Navarro, Alejandro
    Laura Ortega, Ana
    Puente, Javier
    Verger, Eugenia
    Bartolome, Adela
    Nadal, Ernest
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2019, 138 : 190 - 206
  • [48] Separating or combining immune checkpoint inhibitors (ICIs) and radiotherapy in the treatment of NSCLC brain metastases
    Li, Wang
    Yu, Hong
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (01) : 137 - 152
  • [49] Separating or combining immune checkpoint inhibitors (ICIs) and radiotherapy in the treatment of NSCLC brain metastases
    Wang Li
    Hong Yu
    Journal of Cancer Research and Clinical Oncology, 2020, 146 : 137 - 152
  • [50] Systemic Treatment and Radiation Necrosis Following Gamma Knife Radiosurgery in the Treatment of Brain Metastases
    Colaco, R. J.
    Martin, P.
    Bond, J. S.
    Bindra, R. S.
    Contessa, J. N.
    Kluger, H. M.
    Yu, J. B.
    Chiang, V. L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S310 - S310
12345